Physician profile
Pradeep Patel
NPI 1780105783
$1,156.15
in general payments reported to CMS, 2019-2025
15 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.81 · 2023: $362 · 2024: $286 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $433.75 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $167.14 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $148.55 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $94.25 | 2023-2025 | |
| Amgen INC. | $58.02 | 2023-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $48.35 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.79 | 2024-2025 | Xifaxan |
| Dynavax Technologies Corporation | $27.40 | 2023 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $27.00 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $25.08 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $23.03 | 2025 | |
| Inspire Medical Systems, INC. | $19.84 | 2024 | Inspire |
| Eisai INC. | $16.92 | 2024 | |
| Sanofi-Aventis U.S. LLC | $16.40 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.